<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04985097</url>
  </required_header>
  <id_info>
    <org_study_id>CASVENM-20-437</org_study_id>
    <nct_id>NCT04985097</nct_id>
  </id_info>
  <brief_title>Home-based Visual Training in Patients Implanted With Trifocal Diffractive Intraocular Lenses</brief_title>
  <acronym>OPTicTRAIN</acronym>
  <official_title>Preliminary Evaluation of the Clinical Benefit of a Novel Visual Rehabilitation System in Patients Implanted With Trifocal Diffractive Intraocular Lenses: A Blinded Randomized Placebo-controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Increase-Tech</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Alicante</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministerio de Economía y Competitividad, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Increase-Tech</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multicentre randomised controlled trial aimed to reduce the visual discomfort that&#xD;
      patients implanted with trifocal diffractive intraocular lenses may experience after surgery.&#xD;
      To this end, a visual training software (Optictrain) was developed in which Gabor patches&#xD;
      were presented to the patient on a hand-held electronic device. Patients who met all&#xD;
      inclusion criteria and consented to participate underwent half an hour of visual training per&#xD;
      day for a period of 20 consecutive days remotely on a colourimetrically characterised Samsung&#xD;
      Galaxy Tab A device on which the Optictrain software (n=30) or a placebo software (n=30),&#xD;
      respectively, was pre-installed. Corrected and uncorrected near, intermediate and distance&#xD;
      visual acuity (VA) and mesopic near and distance contrast sensitivity (CS) were measured&#xD;
      monocularly and binocularly at two visits: during the first postoperative week (V0) and after&#xD;
      20 days of visual training with the assigned software (V1). The statistical analysis of the&#xD;
      results obtained in the study has not yet been carried out.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">July 20, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Experimental group vs control group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>During the first post-operative week and after 20 days of vision training with the randomly assigned software</time_frame>
    <description>Monocular and binocular corrected and uncorrected visual acuity under near, intermediate and distance conditions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>During the first post-operative week and after 20 days of vision training with the randomly assigned software</time_frame>
    <description>Monocular and binocular mesopic contrast sensitivity under near and distance conditions</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Visual Disturbances and Blindness</condition>
  <condition>Visual Acuity Reduced Transiently</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Half an hour of active visual training per day for a period of 20 consecutive days with the Optictrain software</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Half an hour of using a videogame without specific stimuli to improve visual performance (Fun Kid Racing 3.53 for Android) per day for a period of 20 consecutive days</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Implantation of trifocal diffractive intraocular lenses</intervention_name>
    <description>Postsurgical monocular and binocular assessment of corrected and uncorrected near, intermediate and distance visual acuity and near and distance mesopic contrast sensitivity before and after the assigned vision training</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18 an 90 years&#xD;
&#xD;
          -  Patients implanted with trifocal diffractive intraocular lenses&#xD;
&#xD;
          -  Availability and motivation to perform the visual training assigned&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age under 18 or over 90 years&#xD;
&#xD;
          -  Presence of irregular cornea, illiteracy or cognitive impairment&#xD;
&#xD;
          -  History of eye surgery or presence of any active ocular disease&#xD;
&#xD;
          -  Intraoperative complications leading to significant visual sequelae&#xD;
&#xD;
          -  Patients implanted with monofocal, extended depth of focus or refractive multifocal&#xD;
             IOLs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Medicine, University of Valladolid</name>
      <address>
        <city>Valladolid</city>
        <zip>47005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 26, 2021</study_first_submitted>
  <study_first_submitted_qc>July 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2021</study_first_posted>
  <last_update_submitted>July 31, 2021</last_update_submitted>
  <last_update_submitted_qc>July 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blindness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

